A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

Despite advances in understanding autoimmune diabetes in animal models, there has been little progress in altering the natural course of the human disease, which involves progression to insulin deficiency. Studies with immunosuppressive agents have shown short-term effectiveness, but they have not i...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Diabetes
Main Authors: Herold, Kevan C., Gitelman, Stephen E., Masharani, Umesh, Hagopian, William, Bisikirska, Brygida, Donaldson, David, Rother, Kristina, Diamond, Beverly, Harlan, David M., Bluestone, Jeffrey A.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2005
נושאים:
Immunology and Transplantation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5315015/
https://ncbi.nlm.nih.gov/pubmed/15919798
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים